Report Detail

Pharma & Healthcare Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2019-2025

  • RnM3811760
  • |
  • 11 October, 2019
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Lung Cancer
      • 1.4.3 Colorectal Cancer
      • 1.4.4 Breast Cancer
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Research Institutes and Research Institutions
      • 1.5.4 Clinic
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size
    • 2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends by Regions
      • 2.2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (2019-2025)
      • 2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by by Players
      • 3.1.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by by Players (2014-2019)
      • 3.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players Head office and Area Served
    • 3.3 Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product/Solution/Service
    • 3.4 Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2014-2019)
    • 4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2014-2019)
    • 5.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in North America
    • 5.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
    • 5.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application

    6 Europe

    • 6.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2014-2019)
    • 6.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Europe
    • 6.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
    • 6.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application

    7 China

    • 7.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2014-2019)
    • 7.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in China
    • 7.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
    • 7.4 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application

    8 Japan

    • 8.1 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2014-2019)
    • 8.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Japan
    • 8.3 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
    • 8.4 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2014-2019)
    • 9.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Southeast Asia
    • 9.3 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
    • 9.4 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application

    10 India

    • 10.1 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2014-2019)
    • 10.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in India
    • 10.3 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
    • 10.4 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2014-2019)
    • 11.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Central & South America
    • 11.3 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
    • 11.4 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application

    12 International Players Profiles

    • 12.1 Amgen Inc.
      • 12.1.1 Amgen Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
      • 12.1.4 Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2014-2019))
      • 12.1.5 Amgen Inc. Recent Development
    • 12.2 AstraZeneca Plc
      • 12.2.1 AstraZeneca Plc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
      • 12.2.4 AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2014-2019)
      • 12.2.5 AstraZeneca Plc Recent Development
    • 12.3 Eli Lilly and Co.
      • 12.3.1 Eli Lilly and Co. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
      • 12.3.4 Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2014-2019)
      • 12.3.5 Eli Lilly and Co. Recent Development
    • 12.4 F. Hoffmann-La Roche Ltd.
      • 12.4.1 F. Hoffmann-La Roche Ltd. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
      • 12.4.4 F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2014-2019)
      • 12.4.5 F. Hoffmann-La Roche Ltd. Recent Development
    • 12.5 Novartis AG
      • 12.5.1 Novartis AG Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
      • 12.5.4 Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2014-2019)
      • 12.5.5 Novartis AG Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Epidermal Growth Factor Receptor (EGFR) Inhibitor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epidermal Growth Factor Receptor (EGFR) Inhibitor development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Amgen Inc.
      AstraZeneca Plc
      Eli Lilly and Co.
      F. Hoffmann-La Roche Ltd.
      Novartis AG
      ...

      Market segment by Type, the product can be split into
      Lung Cancer
      Colorectal Cancer
      Breast Cancer
      Others

      Market segment by Application, split into
      Hospital
      Research Institutes and Research Institutions
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Epidermal Growth Factor Receptor (EGFR) Inhibitor status, future forecast, growth opportunity, key market and key players.
      To present the Epidermal Growth Factor Receptor (EGFR) Inhibitor development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Epidermal Growth Factor Receptor (EGFR) Inhibitor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Epidermal Growth Factor Receptor (EGFR) Inhibitor. Industry analysis & Market Report on Epidermal Growth Factor Receptor (EGFR) Inhibitor is a syndicated market report, published as Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Epidermal Growth Factor Receptor (EGFR) Inhibitor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,023.56
      4,535.34
      6,047.11
      3,500.68
      5,251.02
      7,001.36
      423,325.50
      634,988.25
      846,651.00
      277,426.11
      416,139.17
      554,852.22
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report